NCT00819325View on ClinicalTrials.gov

Prevention of Instent Renarrowing With Aggressive Glucose Lowering With Pioglitazone in Diabetic Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

August 31, 2002

Primary Completion Date

November 30, 2006

Study Completion Date

March 31, 2007

Conditions
Coronary Artery DiseaseAngina PectorisType 2 Diabetes MellitusPercutaneous Coronary Intervention
Interventions
DRUG

pioglitazone

pioglitazone 30mg p.o. once a day for 6 months

DRUG

oral hypoglycemic agents

sulfonylurea or metformin

Trial Locations (1)

B3H 3A7

Queen Elizabeth II Health Sciences Centre, Halifax

All Listed Sponsors
collaborator

Nova Scotia Health Research Foundation

OTHER_GOV

lead

Queen Elizabeth II Health Sciences Centre

OTHER

NCT00819325 - Prevention of Instent Renarrowing With Aggressive Glucose Lowering With Pioglitazone in Diabetic Patients | Biotech Hunter | Biotech Hunter